Lakefront Biotherapeutics (LKFT) Non Operating Interest Expenses (2016 - 2026)
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Non Operating Interest Expenses (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Lakefront Biotherapeutics | 1.88 Bn | 1.88 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -160,392.15 |
| Dec 31, 2025 | -3.33 Bn |
| Sep 30, 2025 | -777,421.64 |
| Jun 30, 2025 | -661,064.46 |
| Mar 31, 2025 | -820,469.86 |
| Dec 31, 2024 | -1.78 Bn |
| Sep 30, 2024 | -880,772.04 |
| Jun 30, 2024 | 260,606.79 |
| Mar 31, 2024 | -275,935.89 |
| Dec 31, 2023 | -2.81 Bn |
| Mar 31, 2023 | -905,900.50 |
| Dec 31, 2022 | -10.04 Bn |
| Mar 31, 2022 | -4.72 Mn |
| Mar 31, 2021 | -13.68 Mn |
| Jun 30, 2020 | -2.68 Mn |
| Mar 31, 2020 | -27.46 Mn |
| Dec 31, 2019 | -19.39 Mn |
| Sep 30, 2019 | -42.99 Mn |
| Jun 30, 2019 | -1.65 Mn |
| Mar 31, 2019 | -2.67 Mn |